EMCDDA framework and practical guidance for naming cathinones
Drug Testing and Analysis · 2024
DOI: 10.1002/dta.3662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von Benedikt Pulver und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Bureau of Criminal Investigation Schleswig-Holstein, Forensic Science Institute, Kiel, Germany. Hauptthemen laut MEDLINE: Alkaloids, Psychotropic Drugs. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Monitoring Centre for Drugs and Drug Addiction, Internal Security Fund of the European Union.
Abstract (Originalsprache)
Cathinones are often sold as “legal” alternatives to controlled stimulants such as amphetamine, MDMA and cocaine. Cathinones are the second largest group of new psychoactive substances (NPS), with close to 170 monitored by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Although all cathinones are related to the parent compound cathinone, one of the psychoactive principles in khat, assigning consistent, informative and user‐friendly common names to these substances is challenging. Over time different naming approaches have been applied, leading to cathinones being known by several names. This work provides a framework and practical examples for the consistent naming of cathinones which is easy to understand and can be applied by the forensic community, researchers, clinical practitioners, and policy makers. The scope of the issue and rationale for earlier naming approaches are also discussed. The new naming framework has been developed based on established naming approaches and centered around the common “cathinone,” and “phenone” motifs/scaffolds. The proposed framework establishes clear rules to derive the EMCDDA framework names for cathinones. Each name is, in turn, composed by a principal name containing a parent letter, derived after the “cathinone” or the “phenone” scaffold. Additional substitutions are prepended to the principal name. The framework also provides for exceptions for several cathinones and structural analogs scheduled under UN and EU legislation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Bureau of Criminal Investigation Schleswig-Holstein, Forensic Science Institute, Kiel, Germany.
- Institute of Forensic Medicine, Forensic Toxicology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
ORCID-Profile: Benedikt Pulver
Förderung
- European Monitoring Centre for Drugs and Drug Addiction
- Internal Security Fund of the European Union
Zitieren
APA
Pulver, B., Fischmann, S., Gallegos, A., & Christie, R. (2024). EMCDDA framework and practical guidance for naming cathinones. Drug Testing and Analysis. https://doi.org/10.1002/dta.3662
Vancouver
Pulver B, Fischmann S, Gallegos A, Christie R. EMCDDA framework and practical guidance for naming cathinones. Drug Testing and Analysis. 2024. doi:10.1002/dta.3662
BibTeX
@article{Pulver2024,
author = {Pulver, Benedikt and Fischmann, Svenja and Gallegos, Ana and Christie, Rachel},
title = {EMCDDA framework and practical guidance for naming cathinones},
journal = {Drug Testing and Analysis},
year = {2024},
doi = {10.1002/dta.3662}
}
EUVIMED